Literature DB >> 2420927

Rat brain concentration of administered amino acids: dependence on time of day for administration.

T Eriksson, K Wiesel, A Carlsson.   

Abstract

Several large neutral amino acids (LNAA) (e.g. L-DOPA and L-tryptophan) are used as therapeutic agents. To reach the brain they have to compete with the naturally occurring large neutral amino acids for the saturable, carrier mediated transport into the brain. Since the concentration of LNAA in plasma demonstrates a diurnal rhythm, this competition could be expected to vary accordingly. To investigate if this variation could influence the brain concentration of a certain administered amino acid we injected three groups of rats with L-DOPA, L-tryptophan or saline in the afternoon when the rat plasma concentration of LNAA is at its lowest. Three other groups of rats received the same treatments at 3 a.m., when the concentration of LNAA is reported to be at a maximal level. The brain concentrations of the administered amino acids were significantly higher and LNAA in plasma lower in the groups injected in the afternoon compared with those injected during the night. These findings support the hypothesis that the time of the day when an amino acid is administered is of importance to the concentration of the administered amino acid in the brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420927     DOI: 10.1007/bf01249614

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  11 in total

1.  Daily variations in the concentrations of individual amino acids in rat plasma.

Authors:  J D Fernstrom; F Larin; R J Wurtman
Journal:  Life Sci I       Date:  1971-07-15

2.  Daily rhythms in the concentrations of various amino acids in human plasma.

Authors:  R J Wurtman; C M Rose; C Chou; F F Larin
Journal:  N Engl J Med       Date:  1968-07-25       Impact factor: 91.245

3.  Factors affecting circadian periodicity of blood amino acids in man.

Authors:  R D Feigin; A S Klainer; W R Beisel
Journal:  Metabolism       Date:  1968-09       Impact factor: 8.694

Review 4.  Role of precursor availability in control of monoamine biosynthesis in brain.

Authors:  J D Fernstrom
Journal:  Physiol Rev       Date:  1983-04       Impact factor: 37.312

5.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

6.  Simultaneous measurement of 5-hydroxytryptophan and L-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions.

Authors:  A Shum; M J Sole; G R Van Loon
Journal:  J Chromatogr       Date:  1982-03-12

7.  Circadian periodicity of blood amino-acids in adult men.

Authors:  R D Feigin; A S Klainer; W R Beisel
Journal:  Nature       Date:  1967-07-29       Impact factor: 49.962

8.  Simultaneous determination of femtomole quantities of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in brain using HPLC with electrochemical detection.

Authors:  Z Lacković; M Parenti; N H Neff
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

9.  Adrenergic influence on rat plasma concentrations of tyrosine and tryptophan.

Authors:  T Eriksson; A Carlsson
Journal:  Life Sci       Date:  1982-04-26       Impact factor: 5.037

10.  Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system.

Authors:  O Magnusson; L B Nilsson; D Westerlund
Journal:  J Chromatogr       Date:  1980-12-12
View more
  1 in total

1.  Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Authors:  Rakesh Kumar; Lindsay R Riddle; Suzy A Griffin; Wenhua Chu; Suwanna Vangveravong; Janet Neisewander; Robert H Mach; Robert R Luedtke
Journal:  Neuropharmacology       Date:  2009-02-05       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.